Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Pharmaceuticals & Biotech
Create a narrative
Orexo Community
OM:ORX Community
1
Narratives
written by author
0
Comments
on narratives written by author
4
Fair Values set
on narratives written by author
Community Investing Ideas
Orexo
Popular
Undervalued
Overvalued
Orexo
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Zubsolv Litigation Settlement And OX640 Progress Will Secure Stability
Key Takeaways Legal settlements and strategic changes stabilize revenue streams, enhancing future planning and financial clarity for Orexo. Advancements in product development and strategic partnerships signal potential growth in revenue and net margins.
View narrative
SEK 21.50
FV
4.7% undervalued
intrinsic discount
1.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
ORX
ORX
Orexo
Your Fair Value
SEK
Current Price
SEK 20.50
59.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-240m
824m
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 624.3m
Earnings SEK 91.5m
Advanced
Set Fair Value